Sergio Giralt

Chief Attending, Adult BMT Service

Memorial Sloan Kettering Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sergio Giralt is the Chief Attending of the Adult BMT Service at Memorial Sloan-Kettering Cancer Center in the United States. His research focuses on hematological malignancies, particularly in the areas of chimeric antigen receptor T-cell therapy, allogeneic stem cell transplantation, and the impacts of antifungal prophylaxis in lymphoma patients. Recent publications include studies on humoral vaccine responses, neurologic complications following hematopoietic stem cell transplants, and the application of artificial intelligence in predicting transplant toxicity.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Vikas Gupta

CANADA

View details

Jing Dong

Medical College of Wisconsin

UNITED STATES

View details

Siegfried Janz

Professor & Multiple Myeloma Endowed Chair

Medical College of Wisconsin

UNITED STATES

View details

Juan Carlos Hernandez-Boluda

University of Valencia

SPAIN

View details

Donal P. McLornan

UNITED KINGDOM

View details

Muhammad Bilal Abid

UNITED STATES

View details

Jinru Shia

Professor of Pathology

Weill Cornell Medical College

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sergio Giralt

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies

Post-Transplant Pain and Paralysis: Neurologic Amyotrophy as an Atypical Cause of Shoulder Dysfunction Following Hematopoietic Stem Cell Transplant

Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective Cohort

Artificial Intelligence Enabled Interpretation of ECG Images to Predict Hematopoietic Cell Transplantation Toxicity

Isatuximab for Delayed Red Cell Engraftment after Allogeneic Hematopoietic Cell Transplantation

Increased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy

A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis

Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant

Application of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysis

Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia

EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation

Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy

Collaborators (7)

Vikas Gupta

Jing Dong

Siegfried Janz

Juan Carlos Hernandez-Boluda

Donal P. McLornan

Muhammad Bilal Abid

Jinru Shia

Make your next move.